KRAS and cancer: Based on our previous finding that Sirt2-/- mice develop spontaneous tumors, and a recent study showing that KRAS is acetylated in cancer cells [12], we aimed to determine the role of SIRT2 in KRAS-induced tumorigenesis in vivo.